You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 156 No. 11, November 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Book Reviews and Other Media
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

The Newborn Brain: Neuroscience and Clinical Applications

edited by Hugo Lagercrantz, Mark Hanson, Philippe Evrard, and Charles Rodeck, 550 pp, with 115 illus, $140, ISBN 0521793386, Cambridge, England: Cambridge University Press, 2002.

Arch Pediatr Adolesc Med. 2002;156:1158-1159.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

This wonderful book, which presents the state of the art on how the brain is formed, can be loosely divided into 4 sections. The first section addresses the major events in brain development: neural induction, neurogenesis, neuronal migration, synaptogenesis, the role of neurotrophic factors in development, neurotransmitters and neuromodulators, and glial cell biology. "Molecular Mechanisms for Organising the Developing Central Nervous System" clearly describes the molecular determinants of neurulation and patterning in the central nervous system. The authors very nicely associate mutations in the genes that regulate some of these basic molecular mechanisms with their pathological disease states in humans (eg, mutations in sonic hedgehog with holoprosencephaly). This is followed by an interesting discussion of neuronal migration, which seamlessly links complex molecular mechanisms with human disorders of neuronal migration. The discussion of the effects of neurotransmitters and growth factors is timely because our ability to pharmacologically modulate these systems is . . . [Full Text of this Article]







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.